Related Experiment Videos
Radiation dosimetry for indium-111-pentetreotide
M G Stabin1, P P Kooij, W H Bakker
1Oak Ridge Institute for Science and Education, Tennessee 37831-0117, USA.
Summary
Radiation dose estimates for 111In-pentetreotide show the kidneys receive the highest dose. These findings are crucial for assessing the radiation safety of this diagnostic agent.
Area of Science:
- Nuclear medicine
- Radiopharmacology
- Medical physics
Background:
- 111In-pentetreotide is a radiopharmaceutical used in diagnostic imaging.
- Accurate radiation dose estimation is essential for patient safety.
Purpose of the Study:
- To estimate the radiation dose absorbed by organs and the effective dose from 111In-pentetreotide administration.
- To provide data for evaluating the radiation safety profile of 111In-pentetreotide.
Main Methods:
- Kinetic data were collected from 10 subjects across two study sites.
- A compartmental model was employed to analyze organ retention and excretion patterns.
- Radiation dose calculations were performed based on the gathered kinetic data.
Main Results:
- Data consistency was observed between the two study sites.
- The kidneys were identified as the organ with the highest absorbed radiation dose (0.52 mGy/MBq).
- The calculated effective dose equivalent was 0.1 mSv/MBq, and the effective dose was 0.073 mSv/MBq.
Conclusions:
- The study provides essential radiation dose data for 111In-pentetreotide.
- These estimates form a basis for the radiation safety evaluation of this radiopharmaceutical.
- Findings support informed clinical use and risk-benefit assessment.